je.st
news
Galena Biopharma Inc (GALE) Price Target Lowered to $6.00 at Roth Capital
2016-01-01 17:14:30| Biotech - Topix.net
The brokerage presently has a "buy" rating on the biotechnology company's stock. Roth Capital's price objective indicates a potential upside of 308.16% from the company's current price.
Tags: price
capital
target
gale
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||